Login

Gianmarco Lanza, CEO of FAE Technology SB S.p.A., will be the guest speaker at the upcoming free Smart Webinar. 00:10:00

Share On Facebook Share On Twitter

Videointervista Gianmarco Lanza – CEO FAE Technology

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Empowering Efficiency: Objective Corporation's Commitment to Streamlined Solutions | Tony Walls, Chairman/CEO/Founder of Objective Corp Ltd.
00:10:00
Adrian McArthur Discusses Meridian Mining's Cabasal Project in Brazil
00:10:00
Industry Trends and Innovations in Mining
00:10:00
Economic Futures: Robert Swaak at Impact Nation Live - ABN AMRO | Robert Swaak, CEO , ABN AMRO.
00:10:00
Exploring DSO Affiliations and Private Equity Partnerships: A Deep Dive with Brannon Moncrief, CEO of McLerran & Associates, and Troy W. Eckard of Eckard Enterprises LLC
00:10:00
Importance of Diversifying Custodians for Asset Management
00:10:00
Optimizing Hedged Equity Strategies: Insights from Eric McArdle of Simplify Asset Management | Eric McArdle - Managing Director, Advisor Solutions
00:10:00
The most active company Bittnet in 2017 in using stock exchange mechanisms | Mihai Logofatu, CEO, Bittnet Systems SABNET:BUH
00:10:00
Paul Idelman - Chief Investment Strategist at Russell Investments
00:10:00
Appen CEO Mark Brayan on Worldwide Business with Kathy Ireland | Mark Brayan, CEO, Appen LtdAPX:ASX
00:10:00
Unlocking UK's Cannabis Potential: Celadon Pharmaceuticals' Path| James Short , CEO,Celadon Pharmaceuticals PLC.
00:10:00
Climate change refers to long-term shifts in temperatures and weather patterns|David Danielson,Managing Director,Breakthrough Energy Ventures

© 2017 - Neuhu+